no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses
|
Sohn, Young Mo |
|
2008 |
26 |
13 |
p. 1638-1643 6 p. |
article |
2 |
Basic mathematical models for the temporal dynamics of HAV in medium-endemicity Italian areas
|
Ajelli, Marco |
|
2008 |
26 |
13 |
p. 1697-1707 11 p. |
article |
3 |
Editorial Board
|
|
|
2008 |
26 |
13 |
p. CO2- 1 p. |
article |
4 |
High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus
|
Brehm, K.E. |
|
2008 |
26 |
13 |
p. 1681-1687 7 p. |
article |
5 |
Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague
|
Zauberman, Ayelet |
|
2008 |
26 |
13 |
p. 1616-1625 10 p. |
article |
6 |
Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection
|
Du, Lanying |
|
2008 |
26 |
13 |
p. 1644-1651 8 p. |
article |
7 |
Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions
|
Veits, Jutta |
|
2008 |
26 |
13 |
p. 1688-1696 9 p. |
article |
8 |
Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice
|
Wang, Shixia |
|
2008 |
26 |
13 |
p. 1664-1674 11 p. |
article |
9 |
Residential mobility and uptake of childhood immunisations: Findings from the UK Millennium Cohort Study
|
Pearce, Anna |
|
2008 |
26 |
13 |
p. 1675-1680 6 p. |
article |
10 |
The Developing Countries Vaccine Manufacturers’ Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries
|
Jadhav, Suresh |
|
2008 |
26 |
13 |
p. 1611-1615 5 p. |
article |
11 |
The future of best investing in vaccines: The Health Technology Assessment approach
|
La Torre, Giuseppe |
|
2008 |
26 |
13 |
p. 1609-1610 2 p. |
article |
12 |
TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses
|
Schlosser, Eva |
|
2008 |
26 |
13 |
p. 1626-1637 12 p. |
article |
13 |
Vaccination with recombinant Mycobacterium avium subsp. paratuberculosis proteins induces differential immune responses and protects calves against infection by oral challenge
|
Kathaperumal, Kumanan |
|
2008 |
26 |
13 |
p. 1652-1663 12 p. |
article |